BBIO

$0.00

(

+0.00%

)
Quote details

stock

BridgeBio Pharma Inc

NASDAQ | BBIO

74.21

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$13.77B

Market Cap

-

P/E Ratio

-4.21

EPS

$73.45

52 Week High

$25.34

52 Week Low

HEALTHCARE

Sector

BBIO Chart

Recent Chart
Price Action

BBIO Technicals

Tags:

BBIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $251M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

Revenue & Profitability

Earnings Performance

BBIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $919M
Total Current Assets $721M
Cash And Cash Equivalents At Carrying Value $681M
Cash And Short Term Investments $681M
Inventory -
Current Net Receivables $4.7M
Total Non Current Assets $199M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $24M
Intangible Assets Excluding Goodwill $24M
Goodwill -
Investments -
Long Term Investments $144M
Short Term Investments $0
Other Current Assets $35M
Other Non Current Assets -
Total Liabilities $2.4B
Total Current Liabilities $154M
Current Accounts Payable $9.6M
Deferred Revenue -
Current Debt -
Short Term Debt $4.5M
Total Non Current Liabilities $2.2B
Capital Lease Obligations $9.2M
Long Term Debt $1.7B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7B
Other Current Liabilities $140M
Other Non Current Liabilities $286K
Total Shareholder Equity -$1.5B
Treasury Stock -
Retained Earnings -$3.1B
Common Stock $196K
Common Stock Shares Outstanding $186M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$521M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.1M
Capital Expenditures $933K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $61M
Cashflow From Financing $748M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$543M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $251M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

BBIO News

BBIO Profile

BridgeBio Pharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BridgeBio Pharma, Inc. is a leading biopharmaceutical company based in Palo Alto, California, focusing on the discovery, development, and commercialization of innovative therapies for genetic diseases and rare disorders. With a robust pipeline and a commitment to addressing critical unmet medical needs, BridgeBio employs advanced scientific methodologies to create transformative treatments. The company’s dedication to improving patient outcomes positions it as a formidable player in the genetic medicine space, with a vision to redefine care standards for underserved patient populations.

LPTX
+368.57%
$2.05
PAVS
-40.10%
$0.03
VRAX
+58.18%
$0.62
IXHL
+17.01%
$0.46
IRBT
+68.20%
$3.28
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
ONDS
+11.26%
$8.97
KITT
+106.19%
$1.49
NVDA
-0.72%
$180.14
TWOH
0.00%
$0.00
PLUG
+5.68%
$2.22
NIO
-5.06%
$4.77
IPG
-1.95%
$24.57
TSLA
+4.19%
$447.24
ASST
-1.93%
$1.01
BITF
-0.08%
$3.09
RR
+16.15%
$4.13
AXDX
-61.36%
$0.03
INTC
+0.57%
$43.72
BYND
-6.20%
$1.21
VALE
+3.63%
$13.35
AAL
+2.28%
$14.56
QCLS
+38.46%
$4.68
IREN
+6.23%
$43.68
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
MRVL
+7.15%
$99.54
BMNR
+5.28%
$33.59
NFLX
-5.05%
$103.82
BBD
-2.31%
$3.58
INHD
-8.22%
$0.13
SOND
-23.45%
$0.12
ACHR
+8.43%
$8.29
CAN
+2.04%
$0.96
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
DNN
+4.05%
$2.69
PFE
+2.22%
$25.71
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BMNU
+10.90%
$8.14
MARA
+4.52%
$12.44
SRM
+53.27%
$10.30
F
+0.84%
$13.07
CLSK
+5.30%
$14.43
QBTS
+10.75%
$24.92
KVUE
+0.11%
$16.88
BTBT
+3.34%
$2.31
CIFR
+5.24%
$18.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
PLTD
-2.65%
$6.77
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
WULF
+0.40%
$14.27
AMZN
-0.76%
$232.63
RIVN
+2.64%
$17.68
RGTI
+7.89%
$25.76
GOOGL
+1.63%
$320.97
AMD
+0.76%
$216.88
PLTR
+2.56%
$175.07
AFMD
-34.94%
$0.18
MSFT
-1.57%
$482.27
BAC
+1.79%
$54.14
AG
+2.51%
$15.91
IMRN
-9.19%
$1.58
CHR
-5.80%
$0.04
HBAN
+2.65%
$17.00
ASBP
-8.00%
$0.09
PMAX
+26.43%
$2.87
BMY
+5.65%
$50.98
PCG
-0.78%
$15.20
PYPL
-2.64%
$61.23
HOOD
+6.48%
$134.12
CMND
-12.73%
$0.11
HTOO
+15.71%
$4.05
BTG
+1.01%
$4.47
GTLB
-12.06%
$38.13
CGC
+4.95%
$1.16
MSTR
+3.77%
$188.17
SNAP
+0.20%
$7.63
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
SMR
+6.53%
$20.14
MODV
-25.22%
$0.43
GRAB
-0.85%
$5.21
YGMZ
-13.68%
$0.07
CRCL
+11.27%
$86.16
M
+0.61%
$22.85
AUR
+13.15%
$4.51
PSTG
-26.92%
$69.21
NOK
+1.20%
$6.26
DVLT
-3.19%
$1.82
ABEV
+1.35%
$2.61
ITUB
+0.19%
$7.90
GPUS
-1.01%
$0.28
TSLG
+8.25%
$9.97
CRDO
+10.11%
$188.44
LPTX
+368.57%
$2.05
PAVS
-40.10%
$0.03
VRAX
+58.18%
$0.62
IXHL
+17.01%
$0.46
IRBT
+68.20%
$3.28
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
ONDS
+11.26%
$8.97
KITT
+106.19%
$1.49
NVDA
-0.72%
$180.14
TWOH
0.00%
$0.00
PLUG
+5.68%
$2.22
NIO
-5.06%
$4.77
IPG
-1.95%
$24.57
TSLA
+4.19%
$447.24
ASST
-1.93%
$1.01
BITF
-0.08%
$3.09
RR
+16.15%
$4.13
AXDX
-61.36%
$0.03
INTC
+0.57%
$43.72
BYND
-6.20%
$1.21
VALE
+3.63%
$13.35
AAL
+2.28%
$14.56
QCLS
+38.46%
$4.68
IREN
+6.23%
$43.68
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
MRVL
+7.15%
$99.54
BMNR
+5.28%
$33.59
NFLX
-5.05%
$103.82
BBD
-2.31%
$3.58
INHD
-8.22%
$0.13
SOND
-23.45%
$0.12
ACHR
+8.43%
$8.29
CAN
+2.04%
$0.96
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
DNN
+4.05%
$2.69
PFE
+2.22%
$25.71
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BMNU
+10.90%
$8.14
MARA
+4.52%
$12.44
SRM
+53.27%
$10.30
F
+0.84%
$13.07
CLSK
+5.30%
$14.43
QBTS
+10.75%
$24.92
KVUE
+0.11%
$16.88
BTBT
+3.34%
$2.31
CIFR
+5.24%
$18.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
PLTD
-2.65%
$6.77
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
WULF
+0.40%
$14.27
AMZN
-0.76%
$232.63
RIVN
+2.64%
$17.68
RGTI
+7.89%
$25.76
GOOGL
+1.63%
$320.97
AMD
+0.76%
$216.88
PLTR
+2.56%
$175.07
AFMD
-34.94%
$0.18
MSFT
-1.57%
$482.27
BAC
+1.79%
$54.14
AG
+2.51%
$15.91
IMRN
-9.19%
$1.58
CHR
-5.80%
$0.04
HBAN
+2.65%
$17.00
ASBP
-8.00%
$0.09
PMAX
+26.43%
$2.87
BMY
+5.65%
$50.98
PCG
-0.78%
$15.20
PYPL
-2.64%
$61.23
HOOD
+6.48%
$134.12
CMND
-12.73%
$0.11
HTOO
+15.71%
$4.05
BTG
+1.01%
$4.47
GTLB
-12.06%
$38.13
CGC
+4.95%
$1.16
MSTR
+3.77%
$188.17
SNAP
+0.20%
$7.63
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
SMR
+6.53%
$20.14
MODV
-25.22%
$0.43
GRAB
-0.85%
$5.21
YGMZ
-13.68%
$0.07
CRCL
+11.27%
$86.16
M
+0.61%
$22.85
AUR
+13.15%
$4.51
PSTG
-26.92%
$69.21
NOK
+1.20%
$6.26
DVLT
-3.19%
$1.82
ABEV
+1.35%
$2.61
ITUB
+0.19%
$7.90
GPUS
-1.01%
$0.28
TSLG
+8.25%
$9.97
CRDO
+10.11%
$188.44

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.